|
1
|
Mao JD, Wu P, Huang JX, Wu J and Yang G:
Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth
of large intestinal carcinoma. World J Gastroenterol.
20:12542–12550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shin HR, Carlos MC and Varghese C: Cancer
control in the Asia Pacific region: Current status and concerns.
Jpn J Clin Oncol. 42:867–881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu
L and He J: Report of incidence and mortality in China cancer
registries, 2009. Chin J Cancer Res. 25:10–21. 2013.PubMed/NCBI
|
|
4
|
Wang X, Song ZF, Xie RM, Pei J, Xiang MF
and Wang H: Analysis of death causes of in-patients with malignant
tumors in sichuan cancer hospital of China from 2002 to 2012. Asian
Pac J Cancer Prev. 14:4399–4402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Y, Lv Z, He G, Wang J, Zhang X, Lu G,
Ren X, Wang F, Zhu X, Ding Y, et al: The SOX17/miR-371-5p/SOX2 axis
inhibits EMT, stem cell properties and metastasis in colorectal
cancer. Oncotarget. 6:9099–9112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hayashi H, Beppu T, Sakamoto Y, Miyamoto
Y, Yokoyama N, Higashi T, Nitta H, Hashimoto D, Chikamoto A and
Baba H: Prognostic value of Ki-67 expression in conversion therapy
for colorectal liver-limited metastases. Am J Cancer Res.
5:1225–1233. 2015.PubMed/NCBI
|
|
7
|
Ruers T and Bleichrodt RP: Treatment of
liver metastases, an update on the possibilities and results. Eur J
Cancer. 38:1023–1033. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Downward J: Targeting RAS signalling
pathways in cancer therapy. Nat Rev Cancer. 3:11–22. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Malumbres M and Barbacid M: RAS oncogenes:
The first 30 years. Nat Rev Cancer. 3:459–465. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cherfils J and Zeghouf M: Regulation of
small GTPases by GEFs, GAPs, and GDIs. Physiol Rev. 93:269–309.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu Y, Deng Y, Ji Z, Liu H, Liu Y, Peng H,
Wu J and Fan J: Identification of thyroid carcinoma related genes
with mRMR and shortest path approaches. PLoS one. 9:e940222014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stefanska B, Cheishvili D, Suderman M,
Arakelian A, Huang J, Hallett M, Han ZG, Al-Mahtab M, Akbar SM,
Khan WA, et al: Genome-wide study of hypomethylated and induced
genes in patients with liver cancer unravels novel anticancer
targets. Clin Cancer Res. 20:3118–3132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng M, Bao Y, Li Z, Li J, Gong M, Lam S,
Wang J, Marzese DM, Donovan N, Tan EY, et al: RASAL2 activates RAC1
to promote triple-negative breast cancer progression. J Clin
Invest. 124:5291–5304. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
McLaughlin SK, Olsen SN, Dake B, De Raedt
T, Lim E, Bronson RT, Beroukhim R, Polyak K, Brown M, Kuperwasser C
and Cichowski K: The RasGAP gene, RASAL2, is a tumor and metastasis
suppressor. Cancer Cell. 24:365–378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang Y, Zhao M, Xu H, Wang K, Fu Z, Jiang
Y and Yao Z: RASAL2 down-regulation in ovarian cancer promotes
epithelial-mesenchymal transition and metastasis. Oncotarget.
5:6734–6745. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li N and Li S: RASAL2 promotes lung cancer
metastasis through epithelial-mesenchymal transition. Biochem
Biophys Res Commun. 455:358–362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kamata S and Uchida M: Relationship
between TNM-classification and survival rate in cases of carcinoma
of the oral cavity: A comparison between UICC and AJCC TNM staging
systems. Gan No Rinsho. 32:1339–1343. 1986.(In Japanese).
PubMed/NCBI
|
|
19
|
Cao H, Xu E, Liu H, Wan L and Lai M:
Epithelial-mesenchymal transition in colorectal cancer metastasis:
A system review. Pathol Res Pract. 211:557–569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Karnoub AE and Weinberg RA: Ras oncogenes:
Split personalities. Nat Rev Mol Cell Biol. 9:517–531. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pylayeva-Gupta Y, Grabocka E and Bar-Sagi
D: RAS oncogenes: Weaving a tumorigenic web. Nat Rev Cancer.
11:761–774. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen H, Zhao JY, Qian XC, Cheng ZY, Liu Y
and Wang Z: RASAL1 attenuates gastric carcinogenesis in nude mice
by blocking RAS/ERK signaling. Asian Pac J Cancer Prev.
16:1077–1082. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Calvisi DF, Ladu S, Conner EA, Seo D,
Hsieh JT, Factor VM and Thorgeirsson SS: Inactivation of Ras
GTPase-activating proteins promotes unrestrained activity of
wild-type Ras in human liver cancer. J Hepatol. 54:311–319. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
An J, Lv J, Li A, Qiao J, Fang L, Li Z, Li
B, Zhao W, Chen H and Wang L: Constitutive expression of Bcl-2
induces epithelial-Mesenchymal transition in mammary epithelial
cells. BMC Cancer. 15:4762015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang W, Shi X, Peng Y, Wu M, Zhang P, Xie
R, Wu Y, Yan Q, Liu S and Wang J: HIF-1α promotes
epithelial-mesenchymal transition and metastasis through direct
regulation of ZEB1 in colorectal cancer. PLoS One. 10:e01296032015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Keleg S, Büchler P, Ludwig R, Büchler MW
and Friess H: Invasion and metastasis in pancreatic cancer. Mol
Cancer. 2:142003. View Article : Google Scholar : PubMed/NCBI
|
